TrialCardiovascular diabetology2025

Coronary flow reserve increase after 4-year dapagliflozin treatment in patients with type 2 diabetes: the DAPAHEART follow-up study.

Francesca Cinti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.